https://www.selleckchem.com/pr....oducts/pf-06821497.h
ination therapies, including tyrosine kinase inhibitors. Nonsteroidal antiinflammatory drugs (NSAIDs) have been associated with increased risk of adverse cardiovascular events prompting labeling revisions cautioning their use among patients with cardiovascular disease (CVD). However, little is known regarding long-term trends in real-world prescribing of NSAIDs within the CVD population. We aimed to characterize the use of prescription NSAIDs among U.S. adults with CVD from 1988 to 2016. We used the National Health and Nutrition Exa
Like
Comment
Share
